Specific antibodies to CD47 and PD-l1

PY1885963BActive Publication Date: 2026-09-08JOINT CO BIOCAD
0 Cites 0 Cited by

Patent Information

Application Number
PY1885963
Authority / Receiving Office
PY · PY
Patent Type
Patents
Current Assignee / Owner
Filing Date
2018-10-03
Publication Date
2026-09-08
Patent Text Reader

Abstract

The present invention relates to biotechnology, particularly to antibodies or antigen-binding fragments thereof, and their use. More particularly, the present invention relates to antibodies that bind specifically to CD47 and PD-L1. The invention also relates to a nucleic acid encoding said antibody or antigen-binding fragment thereof, an expression vector, a method for preparing said antibody, and the use of said antibodies and compositions in cancer therapies.
Need to check novelty before this filing date? Find Prior Art